Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A carcinoma that arises from glandular epithelial cells of the fallopian tube
Biomarker and diagnostic research for fallopian tube adenocarcinoma has been reported in the published literature.
3 clinical trials registered. Interventions under study include biologic therapy, drug therapy, and procedural interventions. Pipeline includes 1 PHASE3, 2 PHASE2. Research is sponsored by a mix of industry and academic institutions.
110 publications have been identified in PubMed for fallopian tube adenocarcinoma. Research spans Basic Science / Preclinical (33%), Case Report / Case Series (27%), and Clinical Trial Publication (12%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 36 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 3:34 AM UTC
Patient case studies | 30 | 27% |
Clinical study results | 13 | 12% |
Disease patterns and progression | 10 | 9% |
Research summaries | 9 | 8% |
Testing and diagnosis research | 7 | 6% |
New treatment approaches | 5 | 5% |
Toyoda S (2026). [PMID: 42062843](https://pubmed.ncbi.nlm.nih.gov/42062843/). *Diagn Cytopathol*. [Case Report / Case Series]
Liang B (2026). [PMID: 41217393](https://pubmed.ncbi.nlm.nih.gov/41217393/). *International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists*. [Review / Meta-Analysis]
Kaufmann NA (2026). [PMID: 42009836](https://pubmed.ncbi.nlm.nih.gov/42009836/). *Arch Gynecol Obstet*. [Epidemiology / Natural History]
Soong TR (2026). [PMID: 41923499](https://pubmed.ncbi.nlm.nih.gov/41923499/). *Cancer Res*. [Review / Meta-Analysis]
Pundel OJ (2026). [PMID: 41052931](https://pubmed.ncbi.nlm.nih.gov/41052931/). *Cold Spring Harb Perspect Med*. [Review / Meta-Analysis]
Chui MH (2026). [PMID: 41217360](https://pubmed.ncbi.nlm.nih.gov/41217360/). *Int J Gynecol Pathol*. [Case Report / Case Series]
Chui MH (2026). [PMID: 41397226](https://pubmed.ncbi.nlm.nih.gov/41397226/). *Int J Gynecol Pathol*. [Basic Science / Preclinical]
Machuca-Aguado J (2026). [PMID: 40758752](https://pubmed.ncbi.nlm.nih.gov/40758752/). *International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists*. [Gene Therapy / Novel Therapeutics]
Lengyel K (2026). [PMID: 41808247](https://pubmed.ncbi.nlm.nih.gov/41808247/). *Am J Surg Pathol*. [Basic Science / Preclinical]
Zwimpfer TA (2026). [PMID: 41922350](https://pubmed.ncbi.nlm.nih.gov/41922350/). *Nat Commun*. [Basic Science / Preclinical]